A detailed history of Rice Hall James & Associates, LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Rice Hall James & Associates, LLC holds 2,163,743 shares of BCRX stock, worth $16.6 Million. This represents 0.97% of its overall portfolio holdings.

Number of Shares
2,163,743
Previous 2,079,641 4.04%
Holding current value
$16.6 Million
Previous $12.9 Million 27.95%
% of portfolio
0.97%
Previous 0.84%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$6.41 - $8.69 $539,093 - $730,846
84,102 Added 4.04%
2,163,743 $16.4 Million
Q2 2024

Aug 07, 2024

SELL
$4.13 - $6.79 $296,963 - $488,228
-71,904 Reduced 3.34%
2,079,641 $12.9 Million
Q1 2024

Apr 23, 2024

SELL
$4.89 - $7.65 $223,551 - $349,727
-45,716 Reduced 2.08%
2,151,545 $10.9 Million
Q4 2023

Feb 08, 2024

SELL
$4.98 - $6.77 $390,317 - $530,612
-78,377 Reduced 3.44%
2,197,261 $13.2 Million
Q3 2023

Nov 02, 2023

BUY
$6.71 - $7.92 $2.7 Million - $3.19 Million
402,674 Added 21.5%
2,275,638 $16.1 Million
Q2 2023

Jul 24, 2023

BUY
$6.96 - $8.81 $13 Million - $16.5 Million
1,872,964 New
1,872,964 $13.2 Million

Others Institutions Holding BCRX

About BIOCRYST PHARMACEUTICALS INC


  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.43B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Rice Hall James & Associates, LLC Portfolio

Follow Rice Hall James & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rice Hall James & Associates, LLC with notifications on news.